What is the Level of Serum Leucine-rich α 2-glycoprotein (LRG) Which Predicts Histologic Remission in Patients With Ulcerative Colitis?
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
We attempt to clarify the serum leucine-rich α 2-glycoprotein (LRG) level which can predict histologic remission in ulcerative colitis patients in this study. Colonoscopy with histology will be performed when histologic remission is predicted, irrespective of symptoms or serum LRG values. Serum LRG levels are analyzed by an enzyme-linked immunosorbent assay.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Maximum Age: 90
View:
• active UC patients
Locations
Other Locations
Japan
Showa Inan General Hospital
RECRUITING
Komagane
Contact Information
Primary
Akia Horiuchi
horiuchi.akira@sihp.jp
09021684311
Time Frame
Start Date: 2024-02-25
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 100
Related Therapeutic Areas
Sponsors
Leads: Showa Inan General Hospital